/PRNewswire/ Cognoptix, a groundbreaking diagnostic company for the early-stage detection of Alzheimer s disease (AD), announces today that Marwan Noel.
Share this article
Share this article
MARLBOROUGH, Mass., Jan. 11, 2021 /PRNewswire/ Cognoptix, a privately-held, diagnostics company with a breakthrough technology for the early detection of Alzheimer s disease (AD), announces that the company will present at the 13
th Annual Biotech Showcase™ Digital Event, January 11-15, 2021. Dr. Susanne Wilke, Cognoptix President and CEO, will present an overview of the Cognoptix Sapphire II technology in a talk titled Sapphire II: A Breakthrough Technology For The Early-Stage Detection of Alzheimer s Disease.
Dr. Wilke will discuss Cognoptix Sapphire II technology for early AD detection in the lens of the eye. β-amyloid (Aβ) is expressed in the brain where these neurotoxic peptides aggregate into amyloid plaque. Amyloid plaque is established by National Institute of Aging–Alzheimer Association (NIA-AA) criteria to be the earliest and mandatory hallmark pathology for AD. Extensive research has established that AD-related Aβ ac